Upcoming Webcasts
Avicena presents at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Monday, 11/5/07
Time: 10:15am ET
Click here to listen.
Webcast Archive
Avicena presents at BIO Investor Forum 2006
Thursday, Oct 19, 2006
9:40 a.m. (PST)
Click here to view event.
About Avicena
The Avicena Group, Inc. (OTCBB: AVGO) is a late stage, revenue generating biotechnology company focused on developing products based on its proprietary understanding of the regulation of cellular energy processes. The company’s core technologies, supported by a robust IP portfolio, have broad applications in both pharmaceuticals and dermaceuticals. Avicena’s pharmaceutical program centers on rare neurological disorders (orphan diseases). The company is currently analyzing data from its Phase IIb/III trial in ALS (Amyotrophic Lateral Sclerosis, or Lou Gehrig’s disease). Near term, Avicena intends to initiate both a Phase III trial in Huntington’s disease and a Phase III trial in Parkinson’s disease. Avicena presently derives revenue from the sale of proprietary ingredients to skin care manufacturers. Furthermore, the company is developing a proprietary line of therapeutic skin care products. Avicena’s science is well established and its products are safe and well tolerated. Unlike traditional biotechnology companies, Avicena’s clinical programs are largely funded by government and non-profit organizations.
For an Avicena streaming stock quote, please click the link below:
OTCBB Stock Symbol: AVGO
Note: Stock quotes from the OTC Bulletin Board are delayed 15-20 minutes. You are provided a hyperlink to the OTC Bulletin Board web site for informational purposes only. Avicena Group does not maintain and is not responsible for the content of this web site. Avicena Group makes no representations or warranties with respect to the information contained therein and takes no responsibility for supplementing, updating or correcting any such information.
Resources for Investors
Contact Us
Stay Informed
Subscribe to Avicena Group email alerts.
|
